Characterization of inflammatory markers associated with systemic lupus erythematosus patients undergoing treatment

Conclusion Systemic lupus erythematosus patients receiving standard treatment presented with elevated systemic levels of interleukin-6 and interleukin-10, reduced neutrophil phagocytic capacity, and reduced lymphocyte expression of integrin even when symptoms were in remission. These alterations to innate immune components may put these individuals at a greater risk for acquiring infections.

Source: Revista Brasileira de Reumatologia - March 12, 2016 Category: Rheumatology Source Type: research